Navigation Links
Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer
Date:8/4/2009

competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. Bionovo, Inc. is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Bionovo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Bionovo Announces Closing of Public Offering of Common Stock
2. Bionovo Describes a New Class of Therapeutic Compounds
3. Bionovo Announces 2007 Financial Results and Highlights
4. Bionovo to Present at the Cambria Capital Investor Meeting
5. John D. Baxter, M.D. Joins Bionovos Board of Directors
6. Bionovo to Present at the Rodman & Renshaw 10th Annual Global Investment Conference
7. Bionovo to Present Recent Findings of BN108, its Anticancer Agent, at the 31st Annual San Antonio Breast Cancer Symposium
8. Willa A. Hsueh, M.D., Joins Bionovos Scientific Advisory Board
9. Bionovo Announces Cost Control Measures Taken
10. Bionovo Announces Presentation at the National Cancer Institute
11. Jan Ake Gustafsson, M.D., Ph.D., Joins Bionovos Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... BlockMaster a leading provider of secure USB devices, today launches ... USB flash drive. The software is designed to provide better ... series of new features and range of licensing options. ... ... 2009 -- BlockMaster ( www.blockmastersecurity.com ) a leading provider of ...
(Date:12/15/2009)... Dec. 15 Reportlinker.com announces ... is available in its catalogue: ,, ... in the U.S. and its International ... http://www.reportlinker.com/p0167482/In-Vitro-Diagnostic-Substance-Manufacturing-Industry-in-the-US-and-its-International-Trade-[Q4-2009-Edition].html ,, The newly ... report provides the latest market research ...
(Date:12/15/2009)... 15 Reportlinker.com announces that ... available in its catalogue: ,, ... Therapeutics - Market Forecasts to 2015, ... Analysis ,, http://www.reportlinker.com/p0168100/The-Future-of-Autoimmune-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... The author has released its latest ...
(Date:12/15/2009)... SANTA CLARA, Calif., Dec. 15 ... expansion into Santa Clara County for the ... Effective immediately, Coastal Healthcare Administrators will ... held by the Physicians Foundation for Medical ... based healthcare philosophy, Coastal maintains close working ...
(Date:12/15/2009)... widely thought to be the major form of the ... HIV Research Program (MHRP) researchers, however, have demonstrated that ... to the surface of red blood cells isolated from ... were published today in PLoS ONE , and ... Dr. Zoltan Beck and Dr. Carl Alving, researchers with ...
Breaking Medicine News(10 mins):Health News:BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices 2Health News:BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices 3Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 2Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 3Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 4Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 5Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 6Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 7Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 8Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 18Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 19Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 20Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 21Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 22Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 23Health News:Coastal Healthcare Administrators Expands Provider Network to Santa Clara County 2
... witness the 25th Terry Fox Run on 5 February ... it is expected to further the cause of cancer ... attend the function including 800 children. They can participate ... using motorized transportation. The event is being supported by ...
... caused in human beings due to an excessive use ... which are useful to human beings. // This causes ... who have been undergoing treatment with antibiotics. ... life-threatening complications. But scientists say it has also begun ...
... consent for the novel version of the allergy medicine, Clarinex-D ... congestion occurring in adults and children above the age of ... in time for the spring allergy season. ,It ... are troubled by seasonal allergies with apparent runny nose, sneezing, ...
... services is causing the death of lives and turning ... into miserable. A report submitted by Transparency International on ... findings in a report Global Corruption Report 2006 that ... been hounded by corruption in all levels in hospitals. ...
... Obstructive sleep apnea and chronic snoring can be treated ... can be considered as a first-line treatment, according to ... American Academy of Sleep Medicine. Mouth Guards which are ... as initial treatment. ,The continuous positive ...
... bladder cancer to appear very early in life. ... Georgia in Augusta said that according to the study it ... all shared a history of marijuana smoking. ,She ... suffering from transitional cell bladder cancer. She found that about ...
Other Medicine News:Health News:Congestion for Use of Clarinex-D 12 Hour cleared – FDA Gives the No 2Health News:Corruption and Fraud in Health Care system 2
(Date:12/14/2009)... The 2009 Frost & Sullivan European Product Quality ... on SonoScape. The award recipient has effectively analyzed ... features, pricing, and portability - and introduced the ... this high-end colour Doppler HCU compares with that ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ...
(Date:12/14/2009)... Research Group, Inc. released ChartTrends®: Biologics in ... insight into the management of RA patients. ... self-reported treatment approaches (as reported by 208 Rheumatologists) ... RA patients who are currently being treated with ... audit, patients had to currently be treated with ...
(Date:12/14/2009)... Embarrassing and sometimes uncomfortable colonoscopies may soon be a ... note of a new screening test that is making ... company, EDP Biotech Corporation (EDP) is pursuing ... device doctors can use to screen for colon cancer ... that 30% of colon cancer deaths are avoidable by ...
Breaking Medicine Technology:Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S8 2Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S8 3New Market Research Report from BioTrends Provides Insight on How Rheumatologists are Utilizing Biologic Agents in the Treatment of Rheumatoid Arthritis 2New Market Research Report from BioTrends Provides Insight on How Rheumatologists are Utilizing Biologic Agents in the Treatment of Rheumatoid Arthritis 3EDP Biotech Takes Next Step in the Development of ColoMarker 2EDP Biotech Takes Next Step in the Development of ColoMarker 3NOAA awards funds to improve toxic algal bloom predictions in the Western Gulf of Mexico 10238 1NOAA awards funds to improve toxic algal bloom predictions in the Western Gulf of Mexico 10238 2NTU University of Warwick to collaborate in neuroscience research 10236 1Black rat does not bother Mediterranean seabirds 10234 1Black rat does not bother Mediterranean seabirds 10234 2
... Collaboration Will Seek to Identify Unique microRNA Signatures That Will ... in Lung Cancer Patients,The Project Will Leverage Rosetta Genomics, Proprietary microRNA Extraction, ... ... to Assist in Distinguishing Patients With High Risk, of Recurrence, who ...
... Sangamo Announces Completion of Accrual and Expansion Plans for SB-509-701 Phase ... ... Neuropathy, SAN FRANCISCO, June 6 Sangamo ... its Phase 2 clinical trial (SB-509-701) in subjects with moderate to,severe diabetic ...
Other Medicine Technology:Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer 2Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer 3Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer 4Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer 5Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs 2Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs 3Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs 4Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs 5
... 5mm AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
... Instruments incorporate a layered design unique in ... monitored to prevent stray electrosurgical burns along ... insulation failure or capacitive coupling; a well-documented ... into all AEM Instruments provides a neutral ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Medicine Products: